(E)-2-Benzylidenecyclanones: part XIV. Study on interaction of some (E)-2-benzylidenebenzosuberone derivatives with calf thymus DNA by TLC and UV–Vis methods, a DNA cleavage study
暂无分享,去创建一个
[1] Vivek Asati,et al. Chalcone scaffolds as anti-infective agents: structural and molecular target perspectives. , 2015, European journal of medicinal chemistry.
[2] S. Rehman,et al. Studying non-covalent drug-DNA interactions. , 2015, Archives of biochemistry and biophysics.
[3] Vivek Asati,et al. Anti-cancer chalcones: Structural and molecular target perspectives. , 2015, European journal of medicinal chemistry.
[4] P. Perjési. (E)-2-Benzylidenebenzocyclanones: part XIII—(E)/(Z)-Isomerization of some cyclic chalcone analogues. Effect of ring size on lipophilicity of geometric isomers , 2015, Monatshefte für Chemie - Chemical Monthly.
[5] Mohamed A. Ragheb,et al. DNA binding, photo-induced DNA cleavage and cytotoxicity studies of lomefloxacin and its transition metal complexes. , 2015, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[6] S. Rehman,et al. Interaction of coumarin with calf thymus DNA: deciphering the mode of binding by in vitro studies. , 2015, International journal of biological macromolecules.
[7] V. Tomečková,et al. (E)-2-Benzylidenecycloalkanones XII.* Kinetic Measurement of Bovine and Human Serum Albumine Interaction with Selected Chalcones and Their Cyclic Chalcone Analogues by UV Spectrophotometry , 2015 .
[8] B. Kolundžija,et al. Anthraquinone-chalcone hybrids: synthesis, preliminary antiproliferative evaluation and DNA-interaction studies. , 2015, European journal of medicinal chemistry.
[9] P. Perjési,et al. Naturally occurring chalcones and their biological activities , 2014, Phytochemistry Reviews.
[10] A. Majid,et al. Synthesis of copper(II) complexes of isatin thiosemicarbazone derivatives: In vitro anti-cancer, DNA binding, and cleavage activities , 2014 .
[11] Mohamed B. Khadeer Ahamed,et al. Synthesis of isatin thiosemicarbazones derivatives: in vitro anti-cancer, DNA binding and cleavage activities. , 2014, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[12] B. Mathew,et al. Mechanism of DNA Binding and Cleavage , 2014 .
[13] Cheng-He Zhou,et al. Synthesis and biological evaluation of α-triazolyl chalcones as a new type of potential antimicrobial agents and their interaction with calf thymus DNA and human serum albumin. , 2014, European journal of medicinal chemistry.
[14] P. Viswanathamurthi,et al. Synthesis, characterization, DNA interaction, antioxidant and anticancer activity of new ruthenium(II) complexes of thiosemicarbazone/semicarbazone bearing 9,10-phenanthrenequinone. , 2013, Journal of photochemistry and photobiology. B, Biology.
[15] A. Badshah,et al. Synthesis, chemical characterization, DNA binding and antioxidant studies of ferrocene incorporated selenoure , 2013 .
[16] P. Perjési,et al. Investigation of Interaction of Some Chalcones and Cyclic Chalcone Analogues with Outer Mitochondrial Membrane by UV-VIS and Fluorescence Spectroscopy , 2013 .
[17] Saqib Ali,et al. Drug-DNA interactions and their study by UV-Visible, fluorescence spectroscopies and cyclic voltametry. , 2013, Journal of photochemistry and photobiology. B, Biology.
[18] S. Louro,et al. Cytotoxic activity, albumin and DNA binding of new copper(II) complexes with chalcone-derived thiosemicarbazones. , 2013, European journal of medicinal chemistry.
[19] H. Faidallah,et al. Synthesis, in vitro antitumor evaluation and DNA-binding study of novel tetrahydroquinolines and some derived tricyclic and tetracyclic ring systems. , 2013, European journal of medicinal chemistry.
[20] R. Mehrotra,et al. Spectroscopic studies of the effects of anticancer drug mitoxantrone interaction with calf-thymus DNA. , 2013, Journal of photochemistry and photobiology. B, Biology.
[21] K. Mahadevan,et al. An Efficient One‐Pot Synthesis and Photoinduced DNA Cleavage Studies of 2‐Chloro‐3‐(5‐aryl‐4,5‐dihydroisoxazol‐3‐yl)quinolines. , 2013 .
[22] N. Shahabadi,et al. Binding studies of the antidiabetic drug, metformin to calf thymus DNA using multispectroscopic methods. , 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[23] F. Arjmand,et al. In-vitro DNA binding and cleavage studies with pBR322 of N,N-Bis(3β-acetoxy-5α-cholest-6-yl-idene)hydrazine , 2012 .
[24] M. Mareková,et al. Study of DNA interactions with cyclic chalcone derivatives by spectroscopic techniques. , 2011, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[25] S. Tabassum,et al. Interaction of a ruthenium(II)–chalcone complex with double stranded DNA: Spectroscopic, molecular docking and nuclease properties , 2011 .
[26] P. Perjési,et al. (E)-2-Benzylidenecyclanones: Part VI. Solvent effect on the UV and fluorescence properties of some chalcones and their cyclic analogues. Interaction of 4-dimethylaminochalcones with bovine and human serum albumin: a UV–vis study , 2011 .
[27] P. Solár,et al. In vitro antiproliferative and antiangiogenic effects of synthetic chalcone analogues. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.
[28] Mahdie Rahban,et al. Nanotoxicity and Spectroscopy Studies of Silver Nanoparticle: Calf Thymus DNA and K562 as Targets , 2010 .
[29] V. Tomečková,et al. Assessment of the effect of cyclic chalcone analogues on mitochondrial membrane and DNA , 2009, Central European Journal of Biology.
[30] V. Tomečková,et al. Comparison of effects of some cyclic chalcone analogues on selected mitochondrial functions. , 2008, Die Pharmazie.
[31] E. De Clercq,et al. Design, synthesis and antiproliferative activity of some 3-benzylidene-2,3-dihydro-1-benzopyran-4-ones which display selective toxicity for malignant cells. , 2008, European journal of medicinal chemistry.
[32] Paul J Hergenrother,et al. DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action. , 2007, Current opinion in biotechnology.
[33] S. Al-Shihry,et al. Solvatochromism, DNA binding, antitumor activity and molecular modeling study of mixed-ligand copper(II) complexes containing the bulky ligand: bis[N-(p-tolyl)imino]acenaphthene. , 2007, European journal of medicinal chemistry.
[34] Z. Nowakowska. A review of anti-infective and anti-inflammatory chalcones. , 2007, European journal of medicinal chemistry.
[35] P. Perjési,et al. Different effects of two cyclic chalcone analogues on cell cycle of Jurkat T cells. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.
[36] H. Tajmir-Riahi,et al. DNA Interaction with Naturally Occurring Antioxidant Flavonoids Quercetin, Kaempferol, and Delphinidin , 2005, Journal of biomolecular structure & dynamics.
[37] J. Linnanto,et al. E-2-Benzylidenebenzocycloalkanones. IV. Studies on transmission of substituent effects on 13C NMR chemical shifts of E-2-(X-benzylidene)-1-tetralones, and -benzosuberones. Comparison with the 13C NMR data of chalcones and E-2-(X-benzylidene)-1-indanones , 2005 .
[38] J. Gooding,et al. Electrochemical approach of anticancer drugs--DNA interaction. , 2005, Journal of pharmaceutical and biomedical analysis.
[39] X. Wu,et al. Chalcones: an update on cytotoxic and chemoprotective properties. , 2005, Current medicinal chemistry.
[40] H. Ihmels. Intercalation of Organic Dye Molecules into Double-Stranded DNA - General Principles and Recent Developments , 2005 .
[41] J. Sikorski,et al. Recent advances in therapeutic chalcones , 2004 .
[42] V. Tomečková,et al. Comparison of effect of selected synthetic chalcone analogues on mitochondrial outer membrane determined by fluorescence spectroscopy. , 2004, Journal of biochemical and biophysical methods.
[43] J. Linnanto,et al. E-2-Benzylidenebenzocycloalkanones III. Studies on transmission of substituent effects on IR carbonyl stretching frequencies and 13C NMR chemical shifts of E-2-(X-benzylidene)-1-indanones. Comparison with the IR data of E-2-(X-benzylidene)-1-indanones, -tetralones, and -benzosuberones , 2004 .
[44] E. De Clercq,et al. Correlations between cytotoxicity and topography of some 2-arylidenebenzocycloalkanones determined by X-ray crystallography. , 2002, Journal of medicinal chemistry.
[45] K. Vékey,et al. E-2-benzylidenebenzocyclanones. II. IR and mass spectrometric investigations , 2000 .
[46] J. Dimmock,et al. Bioactivities of chalcones. , 1999, Current medicinal chemistry.
[47] L. Prasad,et al. Conformational and quantitative structure-activity relationship study of cytotoxic 2-arylidenebenzocycloalkanones. , 1999, Journal of medicinal chemistry.
[48] György Tarczay,et al. E-2-Benzylidenebenzocycloalkanones. Stereostructure and NMR spectroscopic investigation , 1999 .
[49] G. Cordell,et al. DNA as an affinity probe useful in the detection and isolation of biologically active natural products. , 1991, Journal of natural products.
[50] J. Marmur. A procedure for the isolation of deoxyribonucleic acid from micro-organisms , 1961 .
[51] S. Rice,et al. A Further Examination of the Molecular Weight and Size of Desoxypentose Nucleic Acid , 1954 .